Streetbeat News

Products Services

ELEV

Elevation Oncology has expanded its Phase 1 clinical trial of EO-3021 to include Japan, marking the first international patient dosing outside the United States. This expansion signifies a significant step in the global development of EO-3021, potentially impacting the company's valuation and investor interest.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:35 pm

CGC

Canopy Growth has expanded its adult-use cannabis portfolio by introducing five new pre-roll products under its 7ACRES and Hiway brands. This move aims to strengthen its market position and cater to the growing demand for pre-rolled cannabis products.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:34 pm

CARS

Cars.com forecasts Q1 revenue of $179M-$181M, indicating a 7%-8% year-over-year growth, driven by Dealer revenue, the D2C acquisition, and the 2023 Marketplace Repackaging Initiative. OEM and National Advertising spend is expected to increase, with overall revenue growth guidance of 6%-8% for the year. Adjusted EBITDA margin is projected to be 27%-29% for Q1, with an expected improvement to 28%-30% for the full year, despite higher Q1 marketing and sales investments.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:33 pm

GOOG

GOOGL

Elon Musk, founder of xAI, highlighted the significance of their Grok AI chatbot in the pursuit of truth, especially in light of the recent controversy surrounding Google's Gemini AI for inaccuracies and bias. Musk announced that Grok version 1.5 will be released in two weeks, emphasizing its rapid improvement and commitment to truth. This comes after Google's Gemini AI faced criticism for generating inaccurate images of historical figures, leading to the suspension of this feature by Alphabet Inc.

Portfolio Pulse from Rounak Jain

February 22, 2024 | 12:33 pm

ITCI

Intra-Cellular Therapies projects its 2024 CAPLYTA net product sales to be between $645 million and $675 million.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:32 pm

RVSN

Rail Vision (RVSN) will present its AI-driven safety systems at the American Short Line and Regional Railroad Association's 2024 Annual Conference & Exhibition. This event is a significant opportunity for RVSN to showcase its innovative solutions to a targeted audience in the railroad industry, potentially leading to increased interest and adoption of its technology.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:25 pm

TD

TD Asset Management, a part of Toronto Dominion Bank, has expanded its offerings by introducing a new actively managed fixed income ETF. This addition is aimed at enhancing their solution suite for investors seeking diversified fixed income options.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:21 pm

ARQQ

Arqit Quantum Inc. and CableFree have announced the availability of integrated quantum-safe cellular technology products for private 5G networks, utilizing symmetric key agreement. This development marks a significant step towards enhancing the security of 5G networks against quantum computing threats.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:19 pm

ECDA

ECD Automotive Design recently sold a highly customized electric Land Rover Defender 90 for over $400,000, marking the company's highest sale price to date and exceeding its historical average selling price by more than 20%.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:17 pm

MNPR

Monopar Therapeutics Inc. announced promising preclinical data for its MNPR-101 radiopharmaceutical program, showing increased tumor uptake and minimized healthy tissue uptake. This program targets cancers expressing the uPAR, including triple-negative breast, colorectal, and pancreatic cancers.

Portfolio Pulse from Charles Gross

February 22, 2024 | 12:12 pm